论文信息 - Reduced Dose-Intensity Subcutaneous Bortezomib Plus Prednisone (VP) Or Plus Cyclophosfamide (VCP) Or Plus Melphalan (VMP) For Newly Diagnosed Multiple Myeloma Patients Older Than 75 Years Of Age - 字舞流文

Reduced Dose-Intensity Subcutaneous Bortezomib Plus Prednisone (VP) Or Plus Cyclophosfamide (VCP) Or Plus Melphalan (VMP) For Newly Diagnosed Multiple Myeloma Patients Older Than 75 Years Of Age

P. Sonneveld | M. Boccadoro | D. Rossi | A. Larocca | R. Mina | T. Guglielmelli | V. Innao | F. Morabito | A. Romano | F. Cavallo | A. Palumbo | A. Liberati | M. Petrucci | C. Nozzoli | M. Offidani | A. Carella | V. Federico | G. Benevolo | S. Oliva | A. Falcone | G. Mansueto | D. Derudas | T. Caravita | E. Saraci | V. Magarotto | S. Gentili